is zepbound a glp-1 agonist New studies suggest drugs may have cancer-preventive effects Zepbound: How It Works, How

they are trying to understand how appetite, food noise, hydration, side effects, dose timing, weight, and progress fit together

Another novel glucose-lowering agent is tirzepatide which has a dual mechanism of action: a GLP-1 and a glucose-dependent insulinotropic polypeptide (GIP) co-agonist

The distinction is between the weight loss branded versions (Wegovy, Zepbound, Saxenda) and the diabetes-indicated versions of the same active ingredients

GLP-1 medications have quickly become one of the most talked-about breakthroughs in medical weight loss

In this regard, TNF- has been demonstrated to trigger the NF-B pathway in EECs, which are a target of the GLP-1/GLP-1R pathway

Parkinsons disease, characterized by dopaminergic neuronal loss in the substantia nigra leading to motor and non-motor symptoms, has also been linked to insulin resistance and impaired cerebral insulin signaling.128 GLP-1RAs and GLP-1/GIP dual-receptor agonists have demonstrated the capacity to enhance insulin sensitivity and exert antioxidant and anti-inflammatory effects in the brain.129 Preclinical studies in various PD animal models indicate that GLP-1RAs such as liraglutide, semaglutide, and lixisenatide promote dopamine synthesis and elevate striatal dopamine levels, thereby conferring neuroprotection to dopaminergic neurons.130132 The dual agonist telpor similarly exhibits neuroprotective effects by improving energy metabolism and inhibiting inflammatory pathways in PD models.126 Clinical trials have assessed the efficacy and safety of GLP-1RAs in PD patients with PD